SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
The Gabelli Healthcare & Wellness Trust (GRX) 当前追踪市盈率 (P/E) 为 61.3. 追踪盈利收益率为 1.63%.
本页证实的标准:
- VALUE (15/100, 未通过) — 追踪市盈率远高于标普500平均值约25，表明估值偏高 (P/E 61.3).
- 追踪盈利收益率 1.63% — 低于债券收益率 — 投资者为预期增长而非当前盈利支付溢价。
SharesGrow 综合评分： 49/100 其中 2/7 项标准通过。
SharesGrow 7-Criteria Score
✗
价值
15/100
Price-to-Earnings & upside
Proven by this page
✗
健康
33/100
Debt-to-Equity & liquidity
→ Health
估值概览 — GRX
估值倍数
P/E (TTM)61.3
前瞻 P/EN/A
PEG 比率N/A
前瞻 PEGN/A
P/B 比率0.00
P/S 比率9.21
EV/EBITDA0.0
每股数据
EPS (TTM)$0.15
每股账面价值$0.00
每股营收$1.00
每股自由现金流$0.00
收益率与内在价值
盈利收益率1.63%
股息收益率0.00%
P/E Ratio & Earnings Yield
每股收益 (EPS) 历史
| Year |
EPS（稀释） |
营收 |
净利润 |
净利润率 |
| 2010 |
$0.00 |
$0.00 |
$0.00 |
- |
| 2017 |
$1.60 |
$32.5M |
$31.69M |
97.5% |
| 2018 |
$-0.12 |
$-1.53M |
$-2.28M |
- |
| 2019 |
$2.68 |
$53.76M |
$53.16M |
98.9% |
| 2020 |
$1.23 |
$25.01M |
$24.18M |
96.7% |
| 2021 |
$2.48 |
$43.49M |
$42.74M |
98.3% |
| 2022 |
$-2.78 |
$-46.71M |
$-47.44M |
- |
| 2023 |
$0.03 |
$1.24M |
$422.8K |
34.1% |
| 2024 |
$-0.02 |
$15.07M |
$-285K |
-1.9% |
| 2025 |
$0.15 |
$15.28M |
$2.29M |
15% |
